The following activities will be carried out: survey of risk stratification models and organisational approaches for new screening; analysis of European guidelines and options; definition of cost-effectiveness scenarios and conduction of pooled data analysis from pilot studies with feedback fromWP10 for relevant models; systematic reviews and multidisciplinary analyses (consensus method) to identify knowledge and research gaps in risk-stratified screening for lung, prostate, and gastric cancers (informed by 8.1, 8.2, 8.3, 8.4, 8.5); feedback provision to WP10 on costeffectiveness analysis.
This task will be led by Unicancer, France, co-led by ISPRO, Italy.